BWX Technologies Reports Third Quarter 2026 Results
BWX Technologies, Inc. (BWXT) filed an SEC Form 8-K — Results of Operations and Financial Condition. BWX Technologies Reports Third Quarter 2026 Results • 3Q26 revenues of $953.0 million • 3Q26 net income of $102.0 million, adjusted EBITDA (1) of $179.7 million • 3Q26 diluted GAAP EPS of $1.11, non-GAAP (1) EPS of $1.26 • BWXT Advanced Nuclear Reactor (BANR) technology selected
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The earnings beat and narrowed guidance range are likely to drive short‑term buying interest.
Market read
The release provides fresh earnings data and guidance for a mid‑cap industrial player, offering a clear trading catalyst.
What to watch
Potential headwinds from government budget constraints or supply‑chain disruptions could limit future growth.
BWX Technologies Reports Third Quarter 2026 Results
Third-quarter revenue, GAAP and non-GAAP earnings, adjusted EBITDA and free cash flow increased year over year, led by Commercial Operations growth and improved Government Operations earnings. BWXT reaffirmed revenue guidance and tightened its adjusted EBITDA, non-GAAP EPS and free cash flow ranges.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Revenue, three months ended September 30, 2026GAAP | $953M | – | 10% |
| Operating income, three months ended September 30, 2026GAAP | $132.1M | – | 17% |
| Operating income, three months ended September 30, 2026non-GAAP | $149.7M | – | 19% |
| Net income, three months ended September 30, 2026GAAP | $102M | – | 24% |
| Net income, three months ended September 30, 2026non-GAAP | $116.3M | – | 27% |
| Diluted EPS, three months ended September 30, 2026GAAP | $1.11 | – | 25% |
| Diluted EPS, three months ended September 30, 2026non-GAAP | $1.26 | – | 26% |
| Adjusted EBITDA, three months ended September 30, 2026non-GAAP | $179.7M | – | 19% |
| Operating cash flow, three months ended September 30, 2026GAAP | $202.7M | – | 42% |
| Capital expenditures, three months ended September 30, 2026other | $52.3M | – | 8% |
| Free cash flow, three months ended September 30, 2026non-GAAP | $150.5M | – | 59% |
| Dividends paid, three months ended September 30, 2026other | $24.7M | – | 8% |
| Effective tax rate, three months ended September 30, 2026GAAP | 22.7% | – | – |
| Effective tax rate, three months ended September 30, 2026non-GAAP | 22.2% | – | – |
| Revenue, nine months ended September 30, 2026GAAP | $ 2,714,814 | – | – |
| Operating income, nine months ended September 30, 2026GAAP | 352,907 | – | – |
| Net income, nine months ended September 30, 2026GAAP | $282.3M | – | – |
| Diluted EPS, nine months ended September 30, 2026GAAP | $ 3.06 | – | – |
| Net cash provided by operating activities, nine months ended September 30, 2026GAAP | 451,718 | – | – |
| Purchases of property, plant and equipment, nine months ended September 30, 2026other | (136,200) | – | – |
| Total backlog, September 30, 2026other | $ 8,556,190 | – | – |
| Total bookings, three months ended September 30, 2026other | $ 538,222 | – | – |
| Total bookings, nine months ended September 30, 2026other | $ 3,437,452 | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Government Operations, three months ended September 30, 2026Growth in special materials and advanced nuclear, partially offset by lower volume in naval propulsion. | $639.1M | – | 4% |
| Commercial Operations, three months ended September 30, 2026Growth in commercial nuclear components, services and medical, partially offset by slightly lower fuel handling revenue. | $314.2M | – | 25% |
| Government Operations, nine months ended September 30, 2026Segment operating income was $ 327,416, adjusted EBITDA was not reported for the nine-month period, backlog was $ 6,481,803, and bookings were $ 2,758,269. | $ 1,818,266 | – | – |
| Commercial Operations, nine months ended September 30, 2026Segment operating income was 74,651, adjusted EBITDA was not reported for the nine-month period, backlog was 2,074,387, and bookings were 679,183. | 900,360 | – | – |
Year ending December 31, 2026 outlook
- Revenue~$3,800
- NoteAdjusted EBITDA (non-GAAP): ~$667
- NoteNon-GAAP earnings per share: $4.72 - $4.77
- NoteFree cash flow (non-GAAP): $350 - $360 million
- NotePreliminary 2027 outlook: high-single-digit revenue growth.
- NotePreliminary 2027 outlook: high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth.
Capital returns
- BWXT paid $24.7 million, or $0.27 per common share, to shareholders in the third quarter of 2026.
- On October 28, 2026, the Board declared a quarterly cash dividend of $0.27 per common share payable on December 10, 2026, to shareholders of record on November 19, 2026.
- Dividends paid to common shareholders for the nine months ended September 30, 2026 were (75,183).
- Repurchases of common stock for the nine months ended September 30, 2026 were —.
What drove it
- Government Operations revenue growth was driven by special materials and advanced nuclear, partly offset by lower naval propulsion volume.
- Commercial Operations revenue growth was driven by commercial nuclear components, services and medical, partly offset by slightly lower fuel handling revenue.
- Government Operations adjusted EBITDA was $144.2 million, up 22%, reflecting higher revenue and strong operating performance across business lines.
- Commercial Operations adjusted EBITDA was $41.4 million, up 17%; higher revenue was partly offset by product and service line mix and SG&A investment to support growth.
- Operating cash flow increased with higher net income, increased advanced billings and working-capital management, partly offset by timing of income tax payments.
- GAAP EPS benefited from higher operating income, lower interest expense and a lower effective tax rate, partly offset by lower other income and higher restructuring and transformation and acquisition-related costs.
Concerns
- Unallocated Corporate operating expense was $(16.8) million, compared with $(8.0) million, a 111% change.
- Commercial Operations higher revenue was partially offset by product and service line mix and SG&A investment to support growth.
- Government Operations growth was partially offset by lower volume in naval propulsion.
- Total bookings were $ 538,222 for the third quarter of 2026, compared with $ 2,245,434 in the prior-year quarter.
- The company cited federal budget uncertainty, potential government shutdowns, changing funding and acquisition priorities, supply-chain and labor-market challenges, and contract delays, changes or termination as risks.
What to watch
- Conversion of the robust bid pipeline into firm awards, as described by management.
- Government Operations demand in special materials, advanced nuclear and naval propulsion.
- Commercial Operations growth in commercial nuclear components, services and medical, and the effect of product and service line mix and SG&A investment.
- Free cash flow delivery against the tightened $350 - $360 million 2026 guidance range.
- Progress toward the preliminary 2027 outlook for high-single-digit revenue growth and high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth.
Balance sheet and cash flow
- Cash and cash equivalents were $ 568,526 at September 30, 2026, compared with $ 499,779 at December 31, 2025.
- Restricted cash and cash equivalents were 3,140 at September 30, 2026, compared with 3,085 at December 31, 2025.
- Long-term debt was 2,021,883 at September 30, 2026, compared with 2,015,983 at December 31, 2025.
- Cash and cash equivalents and restricted cash and cash equivalents at the end of the nine-month period were $ 576,803, compared with $ 86,953.
- Net cash used in investing activities for the nine months ended September 30, 2026 was (304,892), including acquisition of businesses, net of cash acquired, of (186,967).
- Net cash used in financing activities for the nine months ended September 30, 2026 was (81,019).
Analysis
BWXT reported broad year-over-year third-quarter growth. Revenue was $953.0 million, up 10%, while GAAP operating income increased 17% to $132.1 million and GAAP net income increased 24% to $102.0 million. Diluted GAAP EPS was $1.11, up 25%. On a non-GAAP basis, operating income was $149.7 million, net income was $116.3 million and diluted EPS was $1.26, each above the prior-year period.
Both operating segments expanded revenue. Government Operations revenue was $639.1 million, up 4%, driven by special materials and advanced nuclear, although naval propulsion volume was lower. Commercial Operations revenue rose 25% to $314.2 million on commercial nuclear components, services and medical growth. Government Operations adjusted EBITDA increased 22% to $144.2 million and Commercial Operations adjusted EBITDA increased 17% to $41.4 million. Commercial profitability faced product and service line mix and SG&A investment pressure, while consolidated unallocated corporate expense increased to $(16.8) million.
Cash generation strengthened materially in the quarter. Operating cash flow rose 42% to $202.7 million and free cash flow rose 59% to $150.5 million. Management attributed the operating-cash-flow increase to higher net income, increased advanced billings and working-capital management, partly offset by the timing of income tax payments. Third-quarter capital expenditures were $52.3 million, up 8%, primarily reflecting the timing of Commercial Operations growth projects. The company paid $24.7 million of dividends, or $0.27 per common share, during the quarter.
At September 30, 2026, BWXT reported $ 568,526 of cash and cash equivalents and 2,021,883 of long-term debt. Total backlog was $ 8,556,190, including $ 6,481,803 in Government Operations and 2,074,387 in Commercial Operations. Third-quarter total bookings were $ 538,222, compared with $ 2,245,434 in the prior-year quarter. The filing does not provide an explanation for the year-over-year booking change.
For 2026, BWXT reaffirmed revenue guidance of ~$3,800 and tightened adjusted EBITDA guidance to ~$667, non-GAAP EPS guidance to $4.72 - $4.77 and free-cash-flow guidance to $350 - $360 million. The company also introduced preliminary 2027 expectations for high-single-digit revenue growth and high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth. Management stated that the 2027 adjusted EBITDA growth outlook is ahead of the framework provided at its 2026 Investor Day.
Management, verbatim
We had strong third quarter 2026 earnings performance, highlighting our intense focus on operational excellence and cash generation.
Rex. D. Geveden, president and chief executive officer
We are in the early-stages of a multi-decadal investment cycle as our customers seek to address economic security, national security, and energy security challenges with nuclear solutions.
Rex. D. Geveden, president and chief executive officer
As we look to the remainder of 2026 and into 2027, we expect continued demand momentum for nuclear solutions and increased conversion of our robust bid pipeline into firm awards.
Rex. D. Geveden, president and chief executive officer
Not in the filing
stated, not guessed- Gross profit and gross margin were not reported.
- Quarterly balance-sheet cash and debt comparisons were not reported; balance-sheet amounts are reported at September 30, 2026 and December 31, 2025.
- Free cash flow for the nine months ended September 30, 2026 was not reported.
- GAAP guidance was not provided because the company stated it is unable to reliably forecast most items excluded from GAAP results.
- Specific quantitative preliminary 2027 revenue, adjusted EBITDA, non-GAAP EPS and free-cash-flow guidance figures were not reported.
- The filing did not provide a stated reason for the year-over-year decline in total third-quarter bookings.
- The previous outlook covers the full year 2026, and this quarterly release reports only the third quarter, so there is nothing to compare.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
BWXT filed a Form 8‑K announcing its third‑quarter 2026 earnings and updated guidance.
Ticker impact
BWXT reported Q3 2026 results with revenue of $953M, EPS $1.11 GAAP and tightened 2026 non‑GAAP EPS guidance to $4.72‑$4.77.
likely upward pressure as investors price in strong earnings and narrowed guidance ranges
The company posted higher revenue and earnings versus prior year and reaffirmed revenue outlook while narrowing EPS guidance, which typically supports the stock.
Market effects
Strengthens outlook for the nuclear and defense equipment sector.
Positive for U.S. industrial and defense manufacturers.
Reinforces demand for advanced nuclear solutions worldwide.
Counterpoint
Tightened EPS guidance may signal management caution; investors could question margin sustainability.
Key entities
- ExecutiveRex D. Geveden
President and CEO of BWXT who commented on the results.



